Best Medication Treatment For Multiple Sclerosis Clinics and Prices in Turkey for Australians

Turkey hosts several internationally accredited institutions specialising in multiple sclerosis (MS) care. Leading centres such as NP Istanbul Brain Hospital, Hisar Hospital Intercontinental, and Memorial Healthcare Group provide diagnostics, disease-modifying therapies, and neuro-rehabilitation. They use high-field 3T MRI and genetic mapping.

• Specialised infrastructure: NP Istanbul Brain Hospital ranks as Europe’s second-largest brain-focused facility.
• Expert neurologists: Specialists like Dr Celal Salcini manage complex cases including tumefactive MS.
• Diagnostics: Clinics use 3T MRI, genotyping, and drug blood level monitoring.
• Accredited care: Top institutions hold Joint Commission International (JCI) and ISO certifications.
• Integrated rehabilitation: Medipol Mega University Hospital provides robotic-assisted physical therapy for MS.

Bookimed Expert Insight: Patients seeking MS care in Turkey often find significant value at Anadolu Medical Center. This is due to its Johns Hopkins affiliation. This partnership helps treatment protocols align with American standards. Medication costs remain approximately 89% lower than typical Australian prices.

Patient Consensus: Patients recommend checking for specific MS polyclinics in Istanbul rather than general neurology departments. They highlight the importance of English-speaking coordinators and easy MRI access when managing ongoing therapies in Turkey.

Turkish neurology centres provide a full spectrum of multiple sclerosis treatments, including high-efficacy disease-modifying therapies (DMTs), acute relapse management, and advanced neurorehabilitation. JCI-accredited facilities in Istanbul and Ankara offer internationally recognised protocols for relapsing-remitting and progressive MS, so care standards align with global neurological guidelines.

• Disease-modifying therapies: Include oral Mavenclad, injectable Tysabri, and infusion-based Ocrevus (ocrelizumab).
• Acute flare management: High-dose intravenous corticosteroids and plasmapheresis for severe autoimmune neurological relapses.
• Advanced neurorehabilitation: Intensive physical therapy using Lokomat robotic systems and exoskeleton technology for mobility.
• Experimental protocols: Specialised centres evaluate hematopoietic stem cell transplantation (HSCT) for aggressive disease cases.

Bookimed Expert Insight: While many Turkish clinics offer standard DMTs, NP Istanbul Brain Hospital stands out as Europe’s second-ranked brain hospital. They use drug blood level monitoring and genotyping. This allows specialists to personalise dosages, reducing the trial-and-error period common with MS medications.

Patient Consensus: Patients find Turkey provides access to high-efficacy infusions like Ocrevus and Tysabri when local availability is limited. Experience shows that compassionate use programmes through manufacturers can sometimes help with treatment access.

Advanced therapies including Ocrevus and stem cell treatments are accessible in Turkey at JCI-accredited medical centres. Neurologists in Istanbul and Ankara provide Ocrevus infusions and high-intensity haematopoietic stem cell transplantation (HSCT). This is for patients with relapsing and progressive forms of multiple sclerosis.

• Ocrevus infusions: Costs from $10,000 to $15,000 at specialised neurological hubs.
• HSCT protocol: Available at clinics like Hisar Hospital Intercontinental with dedicated bone marrow units.
• Advanced diagnostics: NP Istanbul Brain Hospital uses 3 Tesla MRI for precise disease monitoring.
• Expert care: Specialists like Dr. Abdullah Ozkardes provide stem cell therapy for neurological restoration.
• AU savings: Treatment typically costs $100 to $4,000, saving up to 89%.

Bookimed Expert Insight: While many search for stem cell cures, the most successful outcomes in Turkey come from clinics providing autologous HSCT. This is a medical procedure involving chemotherapy, not just an infusion. Patients should focus on hospitals like Memorial Sisli that hold JCI accreditation and have integrated haematology and neurology departments.

Patient Consensus: Ocrevus is a mainstream treatment in Turkey that offers convenient twice-yearly dosing. Patients recommend verifying the specific immune-ablation protocol if choosing HSCT. This is to ensure it meets international standards.

Turkish neurologists prescribe a range of disease-modifying therapies. These include oral medications like dimethyl fumarate, injectables such as interferons, and high-efficacy infusions like ocrelizumab. Treatment follows international protocols. The aim is to reduce relapse frequency and prevent new brain lesions in patients with relapsing-remitting multiple sclerosis.

• Oral therapies: Specialists frequently prescribe dimethyl fumarate or teriflunomide for treatment-naïve patients.
• Injectable DMTs: Glatiramer acetate and interferon beta formulations remain standard first-line options.
• Infusion therapies: Ocrelizumab and natalizumab are used for highly active or aggressive disease.
• B-cell depletion: Ocrevus infusions occur every 6 months at clinics like Memorial Şişli.

Bookimed Expert Insight: Turkish neurology centres often provide faster access to high-efficacy infusions like Ocrevus. Their wait times are shorter than Australian waiting lists. Specialists at NP Istanbul Brain Hospital typically manage 4,000+ patients annually. This hospital is the second-ranked brain hospital in Europe. This volume ensures neurologists are highly experienced. They are skilled in managing infusion-related side effects and long-term monitoring.

Patient Consensus: Neurologists in Turkey offer both traditional platform therapies and aggressive high-efficacy DMTs. Their choice is based on MRI activity. Patients appreciate the thorough diagnostic monitoring. This includes regular MRI scans and blood tests conducted at major Istanbul centres.